Dawid Krzempek

Mr. Dawid Krzempek

orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 December 2017 in Medical Physics
Verified
Journal Article
Closed access
PDF file
MLMałgorzata Liszka
Małgorzata Liszka
LSLiliana Stolarczyk
Liliana Stolarczyk
MKMagdalena Kłodowska
Magdalena Kłodowska
AKAnna Kozera
Anna Kozera
DKDawid Krzempek
Dawid Krzempek
POPaweł Olko
Paweł Olko

Verified
Journal Article
Open access
PDF file
BKBartosz Klebowski
Bartosz Klebowski
JDJoanna Depciuch
Joanna Depciuch
MSMalgorzata Stec
Malgorzata Stec
DKDawid Krzempek
Dawid Krzempek
WKWiktor Komenda
Wiktor Komenda
MPMagdalena Parlinska-Wojtan
Magdalena Parlinska-Wojtan
Enhancing the effectiveness of colorectal cancer treatment is highly desirable. Radiation-based anticancer therapy—such as proton therapy (PT)—can be used to shrink tumors before subsequent surgical intervention; therefore, improving the effectiveness of this treatment is crucial. The addition of noble metal nanoparticles (NPs), acting as radiosensitizers, increases the PT therapeutic effect. Thus, in this paper, the effect of novel, gold–platinum nanocauliflowers (AuPt NCs) on PT efficiency is determined. For this purpose, crystalline, 66-nm fancy shaped, bimetallic AuPt NCs were synthesized using green chemistry method. Then, physicochemical characterization of the obtained AuPt NCs by transmission electron microscopy (TEM), selected area electron diffraction (SAED), energy dispersive X-ray spectroscopy (EDS), and UV-Vis spectra measurements was carried out. Fully characterized AuPt NCs were placed into a cell culture of colon cancer cell lines (HCT116, SW480, and SW620) and a normal colon cell line (FHC) and subsequently subjected to proton irradiation with a total dose of 15 Gy. The 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium (MTS) test, performed after 18-h incubation of the irradiated cell culture with AuPt NCs, showed a significant reduction in cancer cell viability compared to normal cells. Thus, the radio-enhancing features of AuPt NCs indicate their potential application for the improvement in effectiveness of anticancer proton therapy.

29 November 2022 in Cancers
Verified
Journal Article
Open access
PDF file
BKBartosz Klebowski
Bartosz Klebowski
MSMalgorzata Stec
Malgorzata Stec
JDJoanna Depciuch
Joanna Depciuch
APAgnieszka Panek
Agnieszka Panek
DKDawid Krzempek
Dawid Krzempek
MPMagdalena Parlinska-Wojtan
Magdalena Parlinska-Wojtan
Nano-sized radiosensitizers can be used to increase the effectiveness of radiation-based anticancer therapies. In this study, bimetallic, ~30 nm palladium-platinum nanoparticles (PdPt NPs) with different nanostructures (random nano-alloy NPs and ordered core-shell NPs) were prepared. Scanning transmission electron microscopy (STEM), selected area electron diffraction (SAED), energy-dispersive X-ray spectroscopy (EDS), zeta potential measurements, and nanoparticle tracking analysis (NTA) were used to provide the physicochemical characteristics of PdPt NPs. Then, PdPt NPs were added to the cultures of colon cancer cells and normal colon epithelium cells in individually established non-toxic concentrations and irradiated with the non-harmful dose of X-rays/protons. Cell viability before and after PdPt NPs-(non) assisted X-ray/proton irradiation was evaluated by MTS (3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium) assay. Flow cytometry was used to assess cell apoptosis. The results showed that PdPt NPs significantly enhanced the effect of irradiation on cancer cells. It was noticed that nano-alloy PdPt NPs possess better radiosensitizing properties compared to PtPd core-shell NPs, and the combined effect against cancer cells was c.a. 10% stronger for X-ray than for proton irradiation. Thus, the radio-enhancing features of differently structured PdPt NPs indicate their potential application for the improvement of the effectiveness of radiation-based anticancer therapies.

17 January 2018 in Radiation Protection Dosimetry
Verified
Journal Article
Closed access
PDF file
DKDawid Krzempek
Dawid Krzempek
GMG Mianowska
G Mianowska
NBN Bassler
N Bassler
LSL Stolarczyk
L Stolarczyk
RKRenata Kopec
Renata Kopec
POP Olko
P Olko
Gafchromic EBT3 films are applied in proton radiotherapy for 2D dose mapping because they demonstrate spatial resolution well below 1 mm. However, the film response must be corrected in order to reach the accuracy of dose measurements required for the clinical use. The in-house developed AnalyseGafchromic software allows to analyze and correct the measured response using triple channel dose calibration, statistical scan-to-scan fluctuations as well as experimentally determined dose and LET dependence. Finally, the optimized protocol for evaluation of response of Gafchromic EBT3 films was applied to determine 30 × 40 cm2 dose profiles of the scanning therapy unit at the Cyclotron Centre Bronowice, CCB in Krakow, Poland.

17 January 2018 in Radiation Protection Dosimetry
Verified
Journal Article
Closed access
MRMarzena Rydygier
Marzena Rydygier
MJMarcin Jastrząb
Marcin Jastrząb
DKDawid Krzempek
Dawid Krzempek
TNTomasz Nowak
Tomasz Nowak
LGLeszek Grzanka
Leszek Grzanka
LSLiliana Stolarczyk
Liliana Stolarczyk
Proton radiotherapy requires precise knowledge of the volumetric dose distribution. In proton beam delivery systems, based on narrow pencil beams, a contribution from small doses in low-intensity regions, consisting mainly of scattered protons, may have not negligible influence on total dose delivered to patient. Insufficient information about dose profile can cause underestimation of dose and potential delivery of inflated dose during hadrontherapy treatment. Presented work aims to verify applicability of diamond detectors, produced by Chemical Vapor Deposition method, for therapeutic proton beam profilometry at large fields. This requires the capability of measuring the core of the beam intensity profile (wide dynamic range) as well as its lateral spread (very high sensitivity) with a single device.

29 April 2025 in Physics in Medicine & Biology
Verified
Journal Article
Open access
PSPaulina Stasica-Dudek
Paulina Stasica-Dudek
CGCarlos Granja
Carlos Granja
RKRenata Kopec
Renata Kopec
DKDawid Krzempek
Dawid Krzempek
COCristina Oancea
Cristina Oancea
JGJan Gajewski
Jan Gajewski
Objective. Given the increased interest in incorporating linear energy transfer (LET) as an optimization parameter in intensity-modulated proton therapy (IMPT), a solution for experimental validation of simulations and patient-specific quality assurance (PSQA) in terms of proton LET is needed. Here, we present the methodology and results of LET spectra measurements for spread-out Bragg peak (SOBP) and IMPT plans using a miniaturized pixel detector Timepix3. Approach. We used a MiniPIX Timepix3 detector that provides single-particle tracking, type-resolving power, and spectral information while allowing measurement in quasi-continuous mode. We performed measurements for SOBP and IMPT plans in homogeneous RW3 and heterogeneous CIRS head phantoms with reduced beam current. An artificial intelligence-based model was applied for proton identification and a GPU-accelerated FRED Monte Carlo (MC) code was applied for corresponding MC simulations. Main results. We compared the deposited energy and LET spectra obtained in mixed radiation fields from measurements and MC simulations. The peak positions of deposited energy and LET spectra for the SOBP and IMPT plans agree within the error bars. Discrepancies exceeding the error bars are only visible in the logarithmic scale in high-energy deposition and high-LET tails of the distributions. The mean relative difference of dose-averaged LET values between measurements and MC simulations for individual energy layers is about 5.1%. Significance. This study presents a methodology for assessing radiation quality in proton therapy through energy deposition and LET spectra measurements in uniform and clinical IMPT fields. Findings show an agreement between experimental data and MC simulations, validating our approach. The presented results demonstrate the feasibility of a commercially available Timepix3 detector to validate LET computations in IMPT fields and perform PSQA in terms of LET. This will support the implementation of LET in treatment planning, which will ultimately increase the effectiveness of the treatment.